Cafepharma Today

January 14 2025 - 5 questions facing emerging biotech in 2025
5 questions facing emerging biotech in 2025
Healthcare dealmakers eye M&A resurgence in second Trump term
Reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Merck is broadening its pipeline as Keytruda’s patent cliff looms
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

AstraZeneca Cuts 1,400 Jobs, Fends Off Pulmicort Copy
Bloomberg
Thursday, November 20, 2008 - 1:00pm
tags:
Targanta Tanks On Antibiotic Questions
Forbes
Thursday, November 20, 2008 - 12:59pm
tags:
GlaxoSmithKline buying $217 mln portfolio from AstraZeneca
Marketwatch
Thursday, November 20, 2008 - 11:00am
tags:
Elixir reports positive results from Phase III diabetes trial
Trading Markets
Thursday, November 20, 2008 - 10:08am
tags:
ImClone gets drug candidate manufacturing approval
Yahho/AP
Thursday, November 20, 2008 - 9:57am
tags:
Cash-Rich Drugmakers Eye Mergers or Acquisitions
Yahoo/Businessweek
Thursday, November 20, 2008 - 8:18am
tags:
Waxman Wins Key Vote In Fight With Dingell
Phamalot
Thursday, November 20, 2008 - 8:15am
tags:
SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
Yahoo
Thursday, November 20, 2008 - 8:12am
tags:
AstraZeneca plans to cut 1,400 jobs and close 3 plants in Europe, as growth moves to Asia
Yahoo/AP
Thursday, November 20, 2008 - 8:10am
tags:
PDL hopes to spin off biotech unit by Dec. 18
Bizjournals.com
Thursday, November 20, 2008 - 8:05am
tags:
Prescription Project Welcomes U.S. Appeals Court Ruling in "Data-Mining" Case
PharmaLive
Thursday, November 20, 2008 - 8:01am
tags:
Sanofi Cuts Deal In Legal Battle And Redeploys
Forbes
Thursday, November 20, 2008 - 7:59am
tags:
AstraZeneca Wins Bar on Generic Pulmicort
CNBC
Thursday, November 20, 2008 - 7:58am
tags:
AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals
Seeking Alpha
Thursday, November 20, 2008 - 7:57am
tags:
An FDA committee's vote on Targanta's oritavancin could have a big impact on drug development.
Forbes
Thursday, November 20, 2008 - 7:56am
tags:
Bristol-Myers Squibb Could Rise To Old Highs (BMY)
Investopedia
Thursday, November 20, 2008 - 7:56am
tags:
Depressing News for Drugmakers
Motley Fool
Thursday, November 20, 2008 - 7:55am
tags:
Roche Must Pay $13M In Accutane Lawsuits
Pharmalot
Thursday, November 20, 2008 - 7:53am
tags:
Theravance antibiotic wins FDA panel OK
Bizjournals.com
Thursday, November 20, 2008 - 7:52am
tags:
Pfizer Pulls EU Request for Over-the-Counter Viagra
Bloomberg
Thursday, November 20, 2008 - 7:49am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline
Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns
Drug Channels
Carbyne Remains Elusive
In the Pipeline
Another GLP-1 Year
In the Pipeline
Two More Great Names Pass
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information